029 Group SE

Delisting Announcement • Nov 16, 2006

News Details

Ad-hoc | 16 November 2006 19:36

Rhein Biotech N.V.: Merger with Crucell

Ad hoc announcement transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— PRESS RELEASE Rhein Biotech N.V. proposes to legally merge with Crucell Rhein Biotech N.V. shares to be delisted and to be exchanged for Crucell N.V. shares Maastricht, The Netherlands, November 16, 2006 – Rhein Biotech N.V. (Frankfurt, Geregelter Markt: RBO) today announced the proposal to legally merge Rhein Biotech N.V. with Crucell. Shareholders of Rhein Biotech N.V. will in exchange for each share in Rhein Biotech N.V. receive 1.158 shares in Crucell N.V. The exchange ratio is based on a value of the Rhein Biotech N.V. shares of EUR 21.48 per share, which is approximately 85% above the last trading price of EUR 11.60. Ownership of Rhein Biotech N.V. is currently divided between Berna Biotech AG in Switzerland (itself fully owned by Crucell N.V.), with a 92.7% holding, and other shareholders, who hold the remaining 7.3% of Rhein Biotech N.V. shares. Rhein Biotech N.V. will legally merge into a subsidiary of Crucell N.V., with Crucell N.V. issuing shares. The reason for preparing the delisting of Rhein Biotech N.V. from the Frankfurt stock exchange is to create administrative cost savings and to reduce publication requirements of the Frankfurt stock exchange. A further advantage is that the current Rhein Biotech N.V. shareholders shall obtain Crucell N.V. shares listed on Euronext Amsterdam, which are readily marketable. It is expected that a general meeting of shareholders of Rhein Biotech N.V. will be held on December 22, 2006 and that the merger will be effected before yearend. (c)DGAP 16.11.2006 ————————————————————————— Language: English Issuer: Rhein Biotech N.V. Oude Maasstraat 47 6229 BC Maastricht Niederlande Phone: +31 433 56 78 9-0 Fax: +31 433 56 78 9-9 E-mail: patrik.richard@bernabiotech.com WWW: www.bernabiotech.com ISIN: NL0000230324 WKN: 919544 Indices: Listed: Geregelter Markt in Frankfurt (General Standard); Freiverkehr in Berlin-Bremen, Stuttgart, München, Hamburg, Düsseldorf End of News DGAP News-Service —————————————————————-